Related Experiment Video
Updated: Aug 8, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Current targets in irritable bowel syndrome: an interview with Eamonn Quigley. Interview by Emma Quigley
Abstract:
Eamonn M M Quigley, MD, FACG, is Vice-President of the World Gastroenterology Organisation and Secretary of the American College of Gastroenterology. He is also Professor of Medicine and Human Physiology and Head of the Medical School at the National University of Ireland in Cork. Between 1991 and 1998, he served as Chief of Gastroenterology and Hepatology at the University of Nebraska Medical Center, where he was also Professor in the Department of Internal Medicine. Dr Quigley has been awarded a Fogarty International Fellowship by the National Institutes of Health and an Ainsworth Traveling Scholarship from University College Cork. He completed higher medical training in gastroenterology and internal medicine as a Senior Registrar and Lecturer in the Department of Medicine at Hope Hospital and the University of Manchester. His MD thesis was awarded by the National University of Ireland in 1984 and he received his medical education at University College Cork, graduating MB BCh BAO in 1976. Dr Quigley served as Editor-in-Chief of the American Journal of Gastroenterology from 1997 to 2003, and he has published > 400 articles, including original manuscripts, editorials, review articles, book chapters and case reports. He is also interested and involved in education in the area of gastroenterology and has participated in, or directed symposia, workshops and other teaching forums and prepared a variety of related teaching aids.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Constipation-Predominant IBS
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...